What is VTAK's earnings growth forecast for 2025-2025?
(NYSEMKT: VTAK) Catheter Precision's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 21.05%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.71%.
Catheter Precision's earnings in 2025 is -$23,171,000.
In 2025, VTAK is forecast to generate -$69,408,977 in earnings, with the lowest earnings forecast at -$69,408,977 and the highest earnings forecast at -$69,408,977.
What is VTAK's forecast return on equity (ROE) for 2025-2027?
(NYSEMKT: VTAK) forecast ROE is N/A, which is considered weak.
What is VTAK's Earnings Per Share (EPS) forecast for 2025-2025?
(NYSEMKT: VTAK) Catheter Precision's current Earnings Per Share (EPS) is -$5.34. In 2025, VTAK's EPS is forecast to hit -$6.30 (min: -$6.30, max: -$6.30).
What is VTAK's forecast return on assets (ROA) for 2025-2027?
(NYSEMKT: VTAK) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 12.02%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.